In early tests, researchers saw something they’ve struggled to achieve for years: a male contraceptive that doesn’t disrupt ...
– In control. For years, advocates of reproductive freedom have been waiting for the arrival of male birth control (besides condoms and vasectomies). New options are finally getting closer to ...
Add Yahoo as a preferred source to see more of our stories on Google. Men might finally get a chance to bench their swimmers. A first-of-its-kind male birth control pill just cleared its first human ...
Contraline, a biotech company, has received regulatory approval to move onto Phase 2 of human clinical trials for a male contraceptive that conveniently blocks sperm for up to two years. Contraline ...
As the 2-year anniversary of the overturning of Roe v. Wade approaches, abortion and bodily autonomy remain at the forefront of national conversation. Today, the Senate will vote on the Right to ...
In recent years, a spate of potential male contraceptive options have cropped up. From a hormonal gel that lowers testosterone production to a non-hormonal pill that blocks the creation of vitamin A, ...
This is the first in a two-part episode on Male Birth Control. The next episode will be released 9/26. GRACE AIGNER: Hi everyone! I’m Grace Aigner from the Minnesota Daily, and you’re listening to In ...
This is an archived article and the information in the article may be outdated. Please look at the time stamp on the story to see when it was last updated. (NEXSTAR) – The availability of a reversible ...
When it comes to preventing pregnancy, the burden falls largely on women. But that responsibility could soon shift, according to new research from Columbia University that raises the tantalizing ...
Just a few years ago, the new male contraceptive seemed like an inevitable reality. Major pharmaceutical companies like Wyeth, Schering and Organon were pumping millions into hormonal birth-control ...
Good morning! Kamala Harris breaks her silence after the election, Mexico's president Claudia Sheinbaum warns Trump against tariffs, and Fortune's Nina Ajemian reports on the state of male birth ...